Abatacept efficacy in rheumatoid arthritis is dependent upon baseline blood B-cell levels

被引：17
|
作者：
Gazeau, Pierre [1 ,2 ]
Devauchelle-Pensec, Valerie [1 ,2 ]
Pochard, Pierre [2 ]
Pers, Jacques-Olivier [2 ]
Saraux, Alain [1 ,2 ]
Renaudineau, Yves [2 ,3 ]
Cornec, Divi [1 ,2 ]
机构：
[1] CHRU Brest, Serv Rhumatol, Brest, France
[2] Univ Brest, INSERM ESPRI, ERI29, EA 2216,LabEx IGO, Brest, France
[3] CHRU Brest, Lab Immunol, Brest, France
来源：
RHEUMATOLOGY | 2016年 / 55卷 / 06期
关键词：
ACTIVATION;
D O I：
10.1093/rheumatology/kev417
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1138 / 1140
页数：3
相关论文
共 50 条
  • [31] B-CELL ALLOANTIGENS IN RHEUMATOID-ARTHRITIS (RA)
    SMOLEN, JS
    SCHERAK, O
    MENZEL, EJ
    MAYR, WR
    ZEITSCHRIFT FUR IMMUNITATSFORSCHUNG-IMMUNOBIOLOGY, 1979, 156 (03): : 232 - 233
  • [32] Memory B Cells and Response to Abatacept in Rheumatoid Arthritis
    Gazeau, Pierre
    Alegria, Guillermo Carvajal
    Devauchelle-Pensec, Valerie
    Jamin, Christophe
    Lemerle, Julie
    Bendaoud, Boutahar
    Brooks, Wesley H.
    Saraux, Alain
    Cornec, Divi
    Renaudineau, Yves
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2017, 53 (02) : 166 - 176
  • [33] Memory B Cells and Response to Abatacept in Rheumatoid Arthritis
    Pierre Gazeau
    Guillermo Carvajal Alegria
    Valérie Devauchelle-Pensec
    Christophe Jamin
    Julie Lemerle
    Boutahar Bendaoud
    Wesley H Brooks
    Alain Saraux
    Divi Cornec
    Yves Renaudineau
    Clinical Reviews in Allergy & Immunology, 2017, 53 : 166 - 176
  • [34] COMPARISON OF ABATACEPT EFFICACY AND SAFETY IN DIFFERENT STAGES RHEUMATOID ARTHRITIS
    Maria, K. A.
    Lukina, G. V.
    Sigidin, Y. A.
    Aronova, E. S.
    Glukhova, S. I.
    Luchihina, E. L.
    Karateev, D. E.
    Nasonov, E. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1051 - 1051
  • [35] Efficacy, safety and tolerability of using abatacept for the treatment of rheumatoid arthritis
    Venson, Rafael
    Wiens, Astrid
    Correr, Cassyano Januario
    Pontarolo, Roberto
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 48 (04) : 781 - 791
  • [36] Shared epitope positivity is related to efficacy of abatacept in rheumatoid arthritis
    Oryoji, Kensuke
    Yoshida, Kenji
    Kashiwado, Yusuke
    Tanaka, Keiko
    Mizuki, Shin-ichi
    Tsukamoto, Hiroshi
    Kamada, Kazuo
    Akashi, Koichi
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (08) : 1234 - +
  • [37] Efficacy and safety of abatacept in patients with rheumatoid arthritis with previous malignancy
    Kunishita, Yosuke
    Ichikawa, Kento
    Uzawa, Yuji
    Mitsuhashi, Masaki
    Yoshioka, Yuji
    Okubo, Tadanobu
    Nagaoka, Shouhei
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2023, 15
  • [38] SHARED EPITOPE POSITIVITY IS RELATED TO EFFICACY OF ABATACEPT IN RHEUMATOID ARTHRITIS
    Oryoji, K.
    Yoshida, K.
    Mizuki, S-I.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 565 - 566
  • [39] COMPARISON OF THE EFFICACY OF ABATACEPT ON ELDERLY AND YOUNG PATIENTS WITH RHEUMATOID ARTHRITIS
    Muraoka, S.
    Yamada, Z.
    Hirose, W.
    Kono, H.
    Yasuda, S.
    Nanki, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 988 - 988
  • [40] Abatacept displays low levels of immunogenicity in the treatment of rheumatoid arthritis
    Haggerty, H. G.
    Abbott, M. A.
    Reilly, T. P.
    DeVona, D. A.
    Tay, L. K.
    Aranda, R.
    Block, A. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 319 - 320
12345